Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

BACKGROUND: To analyze the effects of BRCA1/2 mutations on chemotherapy response scores (CRS) and survival in a cohort of patients with advanced-stage ovarian cancer who were treated with neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS). METHODS: We retrospectively reviewe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Lee, Yong Jae, Kim, Hyun-Soo, Rim, John Hoon, Lee, Jung-Yun, Nam, Eun Ji, Kim, Sang Wun, Kim, Sunghoon, Kim, Young Tae
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057666/
https://ncbi.nlm.nih.gov/pubmed/32131779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6688-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires